Testosterone: a vascular hormone in health and disease
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Coronary heart disease is a leading cause of premature death in men. Epidemiological studies have shown a high prevalence of low serum testosterone levels in men with cardiovascular disease (CVD). Furthermore, a low testosterone level is associated in some but not in all observational studies with an increase in cardiovascular events and mortality. Testosterone has beneficial effects on several cardiovascular risk factors, which include cholesterol, endothelial dysfunction and inflammation: key mediators of atherosclerosis. A bidirectional relationship between low endogenous testosterone levels and concurrent illness complicates attempts to validate causality in this association and potential mechanistic actions are complex. Testosterone is a vasoactive hormone that predominantly has vasodilatory actions on several vascular beds, although some studies have reported conflicting effects. In clinical studies, acute and chronic testosterone administration increases coronary artery diameter and flow, improves cardiac ischaemia and symptoms in men with chronic stable angina and reduces peripheral vascular resistance in chronic heart failure. Although the mechanism of the action of testosterone on vascular tone in vivo is not understood, laboratory research has found that testosterone is an L-calcium channel blocker and induces potassium channel activation in vascular smooth muscle cells. Animal studies have consistently demonstrated that testosterone is atheroprotective, whereas testosterone deficiency promotes the early stages of atherogenesis. The translational effects of testosterone between in vitro animal and human studies, some of which have conflicting effects, will be discussed in this review. We review the evidence for a role of testosterone in vascular health, its therapeutic potential and safety in hypogonadal men with CVD, and some of the possible underlying mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–221 of 221
Circulating somatostatin‐28 is not a physiologic regulator of gastric acid production in man
Hildebrand, P., Ensinck, J. W., BUETTIKER, J., Drewe, J., Burckhardt, B., Gyr, K. E., & Beglinger, C. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02059.x · Cited by 36
Dihydrotestosterone alters cyclooxygenase-2 levels in human coronary artery smooth muscle cells
Osterlund, K. L., Handa, R. J., & Gonzales, R. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00693.2009 · Cited by 35
Jiang, P., Xu, J.-W., Zheng, S., Huang, J., Xiang, Q., Fu, X., & Wang, T. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0166 · Cited by 35
Study of androgen and atherosclerosis in old-age male
Yang, Y., Lv, X., Huang, W., Xu, Z., & Wu, L. (2005) · Journal of Zhejiang University. Science A · doi:10.1631/jzus.2005.b0931 · Cited by 34
Androgenic maintenance of the erectile response in the rat
MILLS, T. M., Dai, Y., Stopper, V. S., & Lewis, R. W. (1999) · Steroids · doi:10.1016/s0039-128x(99)00040-9 · Cited by 32
Pugh, P. J., Jones, R. D., Malkin, C. J., Hall, J., Nettleship, J. E., Kerry, K., Jones, T. H., & Channer, K. S. (2005) · Endocrine Research · doi:10.1080/07435800500406205 · Cited by 27
Self-citationPTOV1 : a novel testosterone‐induced atherogenic gene in human aorta
Nakamura, Y., Suzuki, T., Igarashi, K., Kanno, J., Furukawa, T., Tazawa, C., Fujishima, F., Miura, I., Ando, T., Moriyama, N., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1993 · Cited by 22
Erectile dysfunction and coronary disease: Evaluating the link
Jackson, G. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.03.012 · Cited by 22
Jones, R., Ruban, L., Morton, I. E., Roberts, S., ENGLISH, K. M., Channer, K. S., & Jones, T. H. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780381 · Cited by 22
Self-citationNongenomic Actions of Steroids - From the Laboratory to Clinical Implications
Gerdes, D., Christ, M., Rossol-Haseroth, K., Notzon, A., Falkenstein, E., & Wehling, M. (2000) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2000.13.7.853 · Cited by 21
Zuloaga, K. L., & Gonzales, R. J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00446.2011 · Cited by 20
Cardiovascular risk during androgen deprivation therapy for prostate cancer
Jones, T. H. (2011) · BMJ · doi:10.1136/bmj.d3105 · Cited by 18
Self-citationRegitz‐Zagrosek, V., Becher, E., Mahmoodzadeh, S., & Schubert, C. (2008) · Cardiovascular Hormone Systems · doi:10.1002/9783527626236.ch2 · Cited by 16
Focus on Phosphodiesterase Inhibitors for the Treatment of Erectile Dysfunction in Older Men
Lee, M. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.029 · Cited by 15
Testosterone and Prostate Safety
Schulman, C., & Morgentaler, A. (2014) · Springer eBooks · doi:10.1007/978-3-662-45018-5_11 · Cited by 14
Corona, G., Petrone, L., Fisher, A. D., Mansani, R., Bandini, E., Boddi, V., Lotti, F., Forti, G., & Maggi, M. (2008) · PubMed · Cited by 13
Pugh, P. J., Jones, R. D., Jones, T. H., & Channer, K. S. (2002) · Endocrine · doi:10.1385/endo:19:2:155 · Cited by 12
Self-citationVascular actions of 17β‐oestradiol in rat aorta and mesenteric artery
Browne, M., Connolly, C., & Docherty, J. R. (1999) · Journal of Autonomic Pharmacology · doi:10.1046/j.1365-2680.1999.00149.x · Cited by 11
Zitzmann, M., Vorona, E., Wenk, M., Saad, F., & Nieschlag, E. (2009) · Journal of Men s Health · doi:10.1016/j.jomh.2009.08.059 · Cited by 10
Goncharov, N., Katsya, G. V., Gaivoronskaya, L. M., Zoloedov, V. I., Uskov, V. L., & Gooren, L. J. (2012) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2012-0023 · Cited by 10
The effects of testosterone on isolated sheep coronary artery
Yildirim, E. O., & Erol, K. (2011) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2011.086 · Cited by 8
Cited by
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Self-citationKlinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology
Gravholt, C. H., Chang, S., Wallentin, M., Fedder, J., Moore, P., & Skakkebæk, A. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00212 · Cited by 328
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292
Self-citationSociety for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, C. N., Anderson, R. A., Llahana, S., Barth, J. H., MacKenzie, F., Wilkes, S., Smith, N., Sooriakumaran, P., Minhas, S., Wu, F. C. W., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14633 · Cited by 147
Traish, A. M., Haider, A., Haider, K. S., Doros, G., & Saad, F. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417691136 · Cited by 130
Metadata
- Authors
- Kelly, D. M., & Jones, T. H.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2013-04-02
- Volume
- 217
- Issue
- 3
- Pages
- R47-R71
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2123593174
- Cited by
- 293
- References
- 221
- FWCI
- 18.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.